Strengthened capacity of India´s bedaquiline Conditional Access Programme for introducing new drugs and regimens.

Addressing TB in India is critical to meeting global targets. With the scale-up of diagnostic networks and the availability of new TB drugs, India had the opportunity to improve the detection and treatment outcomes in drug-resistant TB (DR-TB). To document how the introduction of new drugs and regimens is helping India improve the care of DR-TB patients.